Sanjay Juneja, Vice President of Tempus AI Clinical Operations, shared a post on LinkedIn:
“You are in for a REAL treat with this one. In 50 minutes, you will understand the MIND BLOWING complexity that sleep, circadian rhythm genes you are born with, and your ability to both fight cancer and respond to cancer therapy–all tie together.
This episode was an enjoyable hybrid of what was ‘Target Cancer: Podcast’ with what is ‘AI and Healthcare’ today. If nothing else, it’ll probably renew some excitement about all of this wearable sleep data we are donning on our extremities… Pump into a foundational model with multomodal, longitudinal outcome data and? Boom.
Many, many thanks to the absolutely brilliant Anne Marie Morse for this one. And of course the eye candy, Douglas Flora.”
Douglas Flora, Executive Medical Director of Yung Family Cancer Center at St. Elizabeth Healthcare, President-Elect of the Association of Cancer Care Centers, and Editor in Chief of AI in Precision Oncology, shared this post, adding:
“I’ll take it. My digital twin, Sanjay Juneja finally understands my REAL contributions to our podcast.
The sleep and cancer episode behind that comment is genuinely worth your time — an hour with one of the leading voices in the field, on a body of evidence moving faster than most oncologists I know can keep up with. A special thanks to Anne Marie Morse for coming on this week, and for blowing both of our minds.
To everyone who tunes in: we feel the momentum, and we appreciate you.
If you haven’t found us yet, scroll back eight or ten episodes. A few months ago we shifted the show to an AI and Healthcare focus, because these tools are landing in clinics, hospitals, and patient living rooms at a pace that demands working clinicians talking honestly about what they see. THE OncDoc and I are having an absurd amount of fun doing it.
New episodes every two weeks. Number 113 drops soon with Google’s brilliant Scott Penberthy and TensorBlack’s own Lindsey B. Cotton stepping up to help as my guest host.
Page link. Subscribe, share with a colleague, and come hunt down the experts with us.”
Other articles featuring Douglas Flora on OncoDaily.